These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 25649991

  • 1. Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients.
    Golla SS, Boellaard R, Oikonen V, Hoffmann A, van Berckel BN, Windhorst AD, Virta J, Haaparanta-Solin M, Luoto P, Savisto N, Solin O, Valencia R, Thiele A, Eriksson J, Schuit RC, Lammertsma AA, Rinne JO.
    J Cereb Blood Flow Metab; 2015 May; 35(5):766-72. PubMed ID: 25649991
    [Abstract] [Full Text] [Related]

  • 2. Parametric Binding Images of the TSPO Ligand 18F-DPA-714.
    Golla SS, Boellaard R, Oikonen V, Hoffmann A, van Berckel BN, Windhorst AD, Virta J, Te Beek ET, Groeneveld GJ, Haaparanta-Solin M, Luoto P, Savisto N, Solin O, Valencia R, Thiele A, Eriksson J, Schuit RC, Lammertsma AA, Rinne JO.
    J Nucl Med; 2016 Oct; 57(10):1543-1547. PubMed ID: 27261521
    [Abstract] [Full Text] [Related]

  • 3. Optimized Quantification of Translocator Protein Radioligand ¹⁸F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers.
    Lavisse S, García-Lorenzo D, Peyronneau MA, Bodini B, Thiriez C, Kuhnast B, Comtat C, Remy P, Stankoff B, Bottlaender M.
    J Nucl Med; 2015 Jul; 56(7):1048-54. PubMed ID: 26025960
    [Abstract] [Full Text] [Related]

  • 4. Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET.
    Ory D, Postnov A, Koole M, Celen S, de Laat B, Verbruggen A, Van Laere K, Bormans G, Casteels C.
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):163-172. PubMed ID: 26323575
    [Abstract] [Full Text] [Related]

  • 5. Impact of Endothelial 18-kDa Translocator Protein on the Quantification of 18F-DPA-714.
    Wimberley C, Lavisse S, Brulon V, Peyronneau MA, Leroy C, Bodini B, Remy P, Stankoff B, Buvat I, Bottlaender M.
    J Nucl Med; 2018 Feb; 59(2):307-314. PubMed ID: 28775204
    [Abstract] [Full Text] [Related]

  • 6. Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging.
    Hamelin L, Lagarde J, Dorothée G, Leroy C, Labit M, Comley RA, de Souza LC, Corne H, Dauphinot L, Bertoux M, Dubois B, Gervais P, Colliot O, Potier MC, Bottlaender M, Sarazin M, Clinical IMABio3 team.
    Brain; 2016 Apr; 139(Pt 4):1252-64. PubMed ID: 26984188
    [Abstract] [Full Text] [Related]

  • 7. Preclinical Evaluation and Quantification of 18F-Fluoroethyl and 18F-Fluoropropyl Analogs of SCH442416 as Radioligands for PET Imaging of the Adenosine A2A Receptor in Rat Brain.
    Khanapur S, van Waarde A, Dierckx RA, Elsinga PH, Koole MJ.
    J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
    [Abstract] [Full Text] [Related]

  • 8. Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide.
    Tang D, Hight MR, McKinley ET, Fu A, Buck JR, Smith RA, Tantawy MN, Peterson TE, Colvin DC, Ansari MS, Nickels M, Manning HC.
    J Nucl Med; 2012 Feb; 53(2):287-94. PubMed ID: 22251555
    [Abstract] [Full Text] [Related]

  • 9. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation.
    Chauveau F, Van Camp N, Dollé F, Kuhnast B, Hinnen F, Damont A, Boutin H, James M, Kassiou M, Tavitian B.
    J Nucl Med; 2009 Mar; 50(3):468-76. PubMed ID: 19223401
    [Abstract] [Full Text] [Related]

  • 10. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
    Jonasson M, Wall A, Chiotis K, Saint-Aubert L, Wilking H, Sprycha M, Borg B, Thibblin A, Eriksson J, Sörensen J, Antoni G, Nordberg A, Lubberink M.
    J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
    [Abstract] [Full Text] [Related]

  • 11. Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation.
    Arlicot N, Vercouillie J, Ribeiro MJ, Tauber C, Venel Y, Baulieu JL, Maia S, Corcia P, Stabin MG, Reynolds A, Kassiou M, Guilloteau D.
    Nucl Med Biol; 2012 May; 39(4):570-8. PubMed ID: 22172392
    [Abstract] [Full Text] [Related]

  • 12. Kinetic modeling and non-invasive approach for translocator protein quantification with 11C-DPA-713.
    Yasuno F, Kimura Y, Ogata A, Ikenuma H, Abe J, Minami H, Nihashi T, Yokoi K, Hattori S, Shimoda N, Ichise M, Sakurai T, Ito K, Kato T.
    Nucl Med Biol; 2022 May; 108-109():76-84. PubMed ID: 35349913
    [Abstract] [Full Text] [Related]

  • 13. Quantification of [18F]florbetapir: A test-retest tracer kinetic modelling study.
    Golla SS, Verfaillie SC, Boellaard R, Adriaanse SM, Zwan MD, Schuit RC, Timmers T, Groot C, Schober P, Scheltens P, van der Flier WM, Windhorst AD, van Berckel BN, Lammertsma AA.
    J Cereb Blood Flow Metab; 2019 Nov; 39(11):2172-2180. PubMed ID: 29897009
    [Abstract] [Full Text] [Related]

  • 14. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
    Van Laere K, Ahmad RU, Hudyana H, Dubois K, Schmidt ME, Celen S, Bormans G, Koole M.
    J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
    [Abstract] [Full Text] [Related]

  • 15. In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET.
    Vicidomini C, Panico M, Greco A, Gargiulo S, Coda AR, Zannetti A, Gramanzini M, Roviello GN, Quarantelli M, Alfano B, Tavitian B, Dollé F, Salvatore M, Brunetti A, Pappatà S.
    Nucl Med Biol; 2015 Mar; 42(3):309-16. PubMed ID: 25537727
    [Abstract] [Full Text] [Related]

  • 16. [18F]DPA-714: Effect of co-medications, age, sex, BMI and TSPO polymorphism on the human plasma input function.
    Peyronneau MA, Kuhnast B, Nguyen DL, Jego B, Sayet G, Caillé F, Lavisse S, Gervais P, Stankoff B, Sarazin M, Remy P, Bouilleret V, Leroy C, Bottlaender M.
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3251-3264. PubMed ID: 37291448
    [Abstract] [Full Text] [Related]

  • 17. Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.
    Endres CJ, Pomper MG, James M, Uzuner O, Hammoud DA, Watkins CC, Reynolds A, Hilton J, Dannals RF, Kassiou M.
    J Nucl Med; 2009 Aug; 50(8):1276-82. PubMed ID: 19617321
    [Abstract] [Full Text] [Related]

  • 18. Comparative Evaluation of Three TSPO PET Radiotracers in a LPS-Induced Model of Mild Neuroinflammation in Rats.
    Sridharan S, Lepelletier FX, Trigg W, Banister S, Reekie T, Kassiou M, Gerhard A, Hinz R, Boutin H.
    Mol Imaging Biol; 2017 Feb; 19(1):77-89. PubMed ID: 27481358
    [Abstract] [Full Text] [Related]

  • 19. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects.
    Varrone A, Oikonen V, Forsberg A, Joutsa J, Takano A, Solin O, Haaparanta-Solin M, Nag S, Nakao R, Al-Tawil N, Wells LA, Rabiner EA, Valencia R, Schultze-Mosgau M, Thiele A, Vollmer S, Dyrks T, Lehmann L, Heinrich T, Hoffmann A, Nordberg A, Halldin C, Rinne JO.
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):438-46. PubMed ID: 25412766
    [Abstract] [Full Text] [Related]

  • 20. Quantification of Tau Load Using [18F]AV1451 PET.
    Golla SSV, Timmers T, Ossenkoppele R, Groot C, Verfaillie S, Scheltens P, van der Flier WM, Schwarte L, Mintun MA, Devous M, Schuit RC, Windhorst AD, Lammertsma AA, Boellaard R, van Berckel BNM, Yaqub M.
    Mol Imaging Biol; 2017 Dec; 19(6):963-971. PubMed ID: 28374171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.